Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for Bruker (BRKR) over the last 12 years, with Q4 2024 value amounting to $1.0 million.

  • Bruker's Asset Writedowns and Impairment fell 6296.3% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $22.6 million, marking a year-over-year increase of 761.9%. This contributed to the annual value of $28.5 million for FY2024, which is 2837.84% up from last year.
  • Per Bruker's latest filing, its Asset Writedowns and Impairment stood at $1.0 million for Q4 2024, which was down 6296.3% from $20.2 million recorded in Q2 2024.
  • In the past 5 years, Bruker's Asset Writedowns and Impairment registered a high of $20.2 million during Q2 2024, and its lowest value of -$1.9 million during Q3 2022.
  • For the 3-year period, Bruker's Asset Writedowns and Impairment averaged around $4.5 million, with its median value being $1.8 million (2022).
  • Per our database at Business Quant, Bruker's Asset Writedowns and Impairment skyrocketed by 1150000.0% in 2023 and then crashed by 7971.01% in 2024.
  • Quarter analysis of 3 years shows Bruker's Asset Writedowns and Impairment stood at $1.6 million in 2022, then surged by 68.75% to $2.7 million in 2023, then crashed by 62.96% to $1.0 million in 2024.
  • Its Asset Writedowns and Impairment was $1.0 million in Q4 2024, compared to $20.2 million in Q2 2024 and $1.4 million in Q1 2024.